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ABSTRACT  
Background: Knowledge about long-term variability of lung function in healthy children is 
essential when monitoring and treating those with respiratory disease over time.  
Aim: To define the natural variability in spirometry in young children after an interval of 
twelve months. 
Methods: The Size and Lung function In Children (SLIC) study was a prospective study 
designed to assess spirometry and body size, shape and composition in a multi-ethnic 
population of London school children. Fourteen schools with a wide range of socio-economic 
circumstances were recruited.  Spirometric and anthropometric assessments and parental 
questionnaires pertaining to respiratory symptoms, previous medical history, pubertal status 
and socio-economic circumstances were completed at baseline and ~one year later. 
Findings: Technically acceptable spirometry data on two occasions ~1y apart (range: 9-
16months) were available in 758 children (39% boys, mean (SD) age:8.1(1.6)y), 593 of 
whom were classified as ‘healthy’. Mean (SD) within-subject between-test variability was 
0.05 (0.6) z-scores, with 95% of all the children achieving a between-test variability within 
±1.2z-scores (equating to ~13%predicted).  
Interpretation: Natural variations of at least 1.2z-scores occur in healthy children over ~1y. 
These must be considered when interpreting results from annual reviews in those with lung 
disease who are otherwise stable if unnecessary further investigations or changes in treatment 
are to be avoided.  
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INTRODUCTION: 
Spirometry assessments are important both for diagnosing lung disease and for monitoring 
disease progression and/or response to treatment.[1-4] While comparison of an individual 
spirometry result with an appropriate reference or predicted value may identify abnormal 
lung function, it is often more clinically valuable to assess changes in an individual’s lung 
function following an intervention or over time.[5] Differentiating true clinical changes in 
pulmonary status from intrinsic between-test variability can however be challenging.   
 
Within-test variability and daily repeatability has been reported to be ~5% in adults[6] and up 
to 10% in young children,[3] although some studies with careful quality control and trained 
subjects have reported within-test variability values as low as 2% in school-aged children.[7]  
While such variability can be controlled to a great extent by using standardised, well 
calibrated equipment and adhering to published guidelines on data collection, analysis and 
quality control,[3 4] identification of clinically important changes over time requires 
knowledge of normal changes in lung function in health, due to growth, development or 
ageing. The recently published Global Lung function Initiative (GLI) spirometry reference 
equations adjust for the main determinants of lung function (age, height, sex and ethnicity) 
and for age-dependent variability,[8] as well as incorporating the important changes in the 
FEV1/FVC ratio that occur during adolescence.[9] These equations, were, however, based on 
cross-sectional data from 74,287 individuals of different ages, and do not necessarily reflect 
individual changes over time.[9]  Although GLI equations have been shown to be applicable 
in cross-sectional studies[10-13] their applicability in longitudinal studies has not been 
investigated.   
 
In contrast to adults in whom there is a steady age-related decline in lung function,[5]
 
which 
is often accelerated by disease,[14] absolute lung function increases during childhood, with 
substantial changes in the pattern of lung and airway growth during puberty,  such that lung 
disease may present as a reduced rate of lung growth, after allowing for the effects of age and 
somatic growth, rather than an absolute decline in overall function.  Identification of 
clinically relevant changes over time in children with lung disease is therefore dependent not 
only on availability of suitable reference equations but on knowing the expected long-term 
variability of lung function in healthy children of similar age. While many studies have 
reported longitudinal changes in lung function either in relation to specific diseases,[15-17] 
or when investigating potential impact of  early life insults,[18-22] there is a relative dearth of 
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information regarding natural variability of  lung function over time, especially in young 
children. 
 
The aim of the study was to define long-term variability in spirometric lung function in a 
multi-ethnic population of London primary school children (5-11 years) after an interval of 
approximately 12 months, and to investigate whether factors such as age, puberty, prior 
history of asthma or mild current respiratory symptoms affected such variability. We 
hypothesised that while there should be no mean change in spirometry outcomes over this 
interval when expressed as z-scores using the GLI multi-ethnic reference equations, the long-
term variability over one year in young children could be at least 10%, as previously reported 
in adults.[5] 
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METHODS: 
The Size and Lung function In Children (SLIC) study was a prospective study designed to 
assess spirometry and body size, shape and composition in a population of multi-ethnic 
children (5-11 years) in London schools.[12] The study protocol, methods of recruitment and 
details of exclusion/inclusion criteria have been published previously.[12] In brief, 14 schools 
with a wide range of socio-economic circumstances (SEC) were recruited. While spirometry 
and anthropometry were assessed in all children with written parental consent, data from 
those with current/chronic lung disease, e.g. sickle cell disease, cystic fibrosis and current 
asthma or with congenital abnormalities likely to impact on lung development were excluded 
from subsequent analyses.[12 13] All children were well enough to attend school, but were 
documented as “symptomatic” if a mild cough or runny nose was observed during the 
measurements.  When possible, both spirometry and anthropometry were repeated 
approximately12 months after the initial assessments.  
 
The same team of paediatric respiratory physiologists carried out all spirometric assessments 
on both test occasions using identical equipment (Easy-on-PC; ndd Medical, Zurich, 
Switzerland) and standardised protocols in accordance with published guidelines,[4] with 
subsequent over-read by a senior respiratory physiologist to ensure appropriate quality 
control.[23] To facilitate high quality data collection, all operators were trained and assessed 
to ensure that they would enthusiastically encourage each child to achieve maximal inhalation 
and exhalation. Furthermore, plenty of time was allowed for a full explanation, practical 
demonstration and subsequent practice with the child prior to commencing the tests.  
 
Results were expressed as z-scores using the GLI spirometry reference equations which 
adjust for sex, age, height and ethnicity.[8]Age was recorded in decimal years.[24] Height 
and weight were measured without shoes to the nearest 0.1cm and 0.1kg respectively 
(Harpenden stadiometer, Holtain Ltd, UK and Tanita BWB600, Tanita Corporation, Tokyo) 
and, together with body mass index (BMI), were converted to z-scores to adjust for sex and 
age.[25]   
 
A questionnaire pertaining to respiratory symptoms, previous medical history, pubertal status 
(if >8 years of age) and SEC (defined using the English Index of Multiple Deprivation 
(IMD)[26] score based on home postcode) was administered on both test occasions.[27] 
Methods of classifying puberty have been described previously.[28] In brief, children were 
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classified as non-pubertal if their parents responded negatively to the relevant questions on 
both test occasions, or as ‘approaching puberty’ if parents responded positively either on both 
occasions or just the second. SEC based on IMD 2010 score was grouped into three 
categories reflecting high (least deprived areas; 1
st
-2
nd
 quintile), moderate (3
rd
-4
th
 quintile) 
and low SEC (most deprived areas; 5
th
 quintile).[26] Children were broadly categorised as: 
White (European ancestry), Black (African or Caribbean descent); South Asian (origin from 
Indian sub-continent) or of “Other” or mixed ethnicities, based on parental report. 
The study was guided by a Steering Committee, and approved by the London-Hampstead 
research ethics committee (REC:10/H0720/53). Parental written consent and child verbal 
assent were obtained prior to assessment.  
Data management and statistical analysis 
Results are presented as mean (SD) for continuous variables or frequencies (%) for 
categorical variables. To adjust for differences in growth and development (age, sex and 
height), lung function results were expressed as z-scores. Mean differences in lung function 
z-scores between test occasions were calculated by subtracting values of 2
nd
 test from those 
of the 1
st
 (i.e. T1-T2) with the 95% limits of these differences calculated as: 
meandifference±1.96SDdifference. This is termed the “between-test variability”. When using the 
GLI equations in 5-11 year-old children, a z-score difference in FEV1 or FVC equates to 
approximately 11% predicted.[8] For the purposes of this study, and to aid clinical 
interpretation, between-test variability was classified as low for those with differences of 
<0.5z-score; moderate if between 0.5 to <1z-score; high if between 1 to <2 z-scores and 
extreme if >2 z-scores. Pearson correlation coefficient (95% confidence intervals (CI)) was 
used to assess the magnitude of any association between changes in lung function and height 
z-scores between test occasions. Both linear and logistic regression models were used to 
evaluate the association of growth factors (i.e. age, height, ‘approaching puberty’) and 
difference in lung function z-scores between tests. Logistic regression models with 95% CI 
described any increased odds of having a difference in lung function between-test occasions 
that exceeded ±0.5z-scores, while the linear regression models evaluated the association of 
growth factors (e.g time interval between tests, onset of puberty, change in height z-score) 
with the change in lung function z-scores. Since results were similar using both methods, 
logistic regression models were presented to aid clinical interpretation. 
Analyses were performed using SPSS v.20 (IBM Corp. Armonk, NY).  
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RESULTS: 
Of the 1901 subjects assessed in the main study,[12] measurements were only possible on a 
single test occasion in 1120, due to lack of facilities in some schools for repeat testing within 
a specified time period, children moving to senior schools or lack of parental consent on one 
or other test occasion.  Results from 23/781 (2.9%) children with repeated measurements 
were excluded due to poor quality spirometry or change in asthma health status between test 
occasions.  
 
Technically acceptable data on two test occasions 9-16 months apart (mean 11.0 months), 
were available in 758 children, hereafter referred to as ‘All Subjects’, a group which 
comprised 39% boys, mean (SD) age on first test occasion: 8.1(1.6) years. Of these, 63 (8%) 
had been born preterm and/or with low birth weight (LBW), 37(5%) had been previously 
diagnosed with asthma and 65 (8.6%) had mild respiratory symptoms on one or other test 
occasion (4% on first test and 4.6% on second test). 44% of ‘All Subjects’ were White, 23% 
Black, 21% South Asian and 12% of ‘Other/Mixed’ ethnicities.  Apart from an increased 
proportion of preterm/low birthweight and a reduced proportion of asthma among South 
Asians, a similar ethnic distribution was observed across all subgroups. With the exception of 
a small reduction in the proportion of boys, background characteristics of children 
undergoing repeated measurements were very similar to those observed for the entire SLIC 
population of 1901 children.[12 27]  Background characteristics  of ‘All Subjects’ as well as 
the various sub-groups  were also very similar to those of the ‘healthy population’ which 
comprised the 593 (78%) children with repeat measurements who had no significant prior or 
current medical history (Figure 1, Table 1).  
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Table 1: Participants’ characteristics 
 
Healthy 
n=593 (39% boys) 
Preterm/LBW 
n = 63 ( 43%boys) 
Prior Asthma 
n= 37 (38%boys) 
Symptomatic 
n = 65 (40%boys) 
1
All Subjects 
n = 758 (39%boys) 
Test Occasion details T1 T2 T1 T2 T1 T2 T1 T2 T1 T2 
      Age (years) 8.1 (1.6) 9.1 (1.6) 8.6 (1.4) 9.5 (1.4) 8.1 (1.6) 9.1 (1.6) 7.7 (1.4) 8.7 (1.5) 8.1 (1.6) 9.1 (1.6) 
     z-Height 0.40 (1.0) 0.48 (1.0) 0.14 (1.2) 0.24 (1.5) 0.63 (1.1) 0.67 (1.1) 0.29 (1.1) 0.37 (1.1) 0.38 (1.0) 0.46 (1.0) 
     z-Weight 0.44 (1.1) 0.50 (1.1) 0.25 (1.5) 0.40 (1.5) 0.80 (1.1) 0.82 (1.2) 0.42 (1.3) 0.46 (1.3) 0.44 (1.2) 0.50 (1.2) 
     z-BMI 0.31 (1.2) 0.35 (1.2) 0.24 (1.5) 0.38 (1.6) 0.63 (1.4) 0.63 (1.4) 0.36 (1.4) 0.38 (1.4) 0.32 (1.3) 0.37 (1.3) 
FEV1(L) mean, range 1.5 (0.5–2.8) 1.7 (0.8-3.8) 1.5 (0.8-2.5) 1.7 (0.8-2.9) 1.5 (0.8-2.1) 1.6 (0.9-2.4) 1.5 (1.1-2.5) 1.8 (1.2-2.7) 1.5 (0.5-2.8) 1.7 (0.8-3.8) 
FVC (L) mean, range 1.8 (0.6-3.4) 2.0 (0.8-4.6) 1.8 (0.9-2.9) 2.0 (1.1-3.2) 1.7 (0.9-2.4) 2.0 (1.1-2.8) 1.8 (1.2-2.6) 2.1 (1.4-3.1) 1.8 (0.6-3.4) 2.0 (0.8-4.6) 
     z-FEV1 0.05 (0.92) -0.02 (0.92) -0.03 (0.85) -0.04 (0.91) -0.35 (0.8) -0.40 (0.9) -0.23 (1.0) -0.20 (1.0) 0.00 (0.94) -0.05 (0.92) 
     z-FVC 0.19 (0.92) 0.15 (0.89) 0.18 (0.99) 0.13 (0.92) 0.00 (0.8) 0.00 (0.6) 0.10 (1.0) 0.18 (1.0) 0.17 (0.92) 0.14 (0.89) 
    z-FEV1/FVC -0.27 (0.97) -0.34 (0.87) -0.39 (0.91) -0.31 (0.85) -0.70 (0.8) -0.78 (0.9) -0.56 (1.2) -0.63 (1.0) -0.32 (0.98) -0.38 (0.89) 
Footnote: 
1
The ‘All subjects’ population includes all children (i.e. healthy + preterm/LBW + prior asthma + symptomatic at test). 
Please note when interpreting paediatric spirometry, results need to be adjusted for age, sex, height and ethnicity by using z-scores, since in the presence of ongoing growth 
changes cannot be based on absolute values 
Abbreviations: T1: test occasion one; T2: test occasion two, LBW: low birth weight, BMI: Body mass Index. Height, weight and BMI z-scores were calculated using British 
1990.[25] Lung function z-scores were calculated using all-age ethnic specific equations (GLI-2012).[8] 
Results are presented as either n (%) or mean (SD). 
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Between 14-24% children in the various populations/sub-groups were ‘approaching puberty’ 
by the second test occasion. Socio-economic circumstances as classified by the IMD 2010 
score were consistent between test occasions in all but 4% of children, the latter being 
classified for the purposes of this study by using information recorded on the second test 
occasion. One third of both ‘All Subjects’ and ‘healthy children’, and nearly half of those 
born preterm  or with ‘previous asthma’ were classified within the lower (5th) quintile 
according to IMD 2010. There were no significant differences in either anthropometry or 
lung function between ‘All Subjects’ and the healthy population, although those with ‘prior 
asthma’ tended to have a higher BMI than other groups and, together with those who were 
symptomatic on day of test, tended to have slightly lower lung function (Table 1). 
 
After an interval of 9 to 16 months, the mean (SD) between-test variability of FEV1 was 0.05 
(0.6) z-scores for ‘All Subjects’.  Two-thirds of ‘All Subjects’ as well as ‘healthy’ children 
had low variability (±0.5 z-scores, i.e. <6% predicted), with similar results for children born 
preterm/LBW or with prior asthma, although this proportion was slightly lower (54%) in 
those who were symptomatic on one or other test occasion (Table 2). Between-test variability 
of between ± 1.2z-score (~13% predicted) was achieved by 95% of all young children 
included in the study with only four children (0.5%) having extreme variability between-test 
occasions (> ±2z-scores) (Table 2). Although results from children with the “extreme 
variability” were re-analysed to verify that this was not due to any issues with quality control, 
this did not lead to any further exclusion.  Those with lung function below the 5
th
 centile on 
the initial visit (<1.64 z-scores) tended to have larger increases in lung function when re-
tested than those in whom results were within the normal range (Figure 2), however there 
was only a weak correlation (r
2
= 0.09) between the magnitude of change over time and lung 
function on the first occasion. 
  
There was no association between changes in z-FEV1 and changes in height z-score between 
test occasions among ‘All Subjects’ (rho=0.09 (95%CI: 0.02; 0.16), suggesting that the more 
extreme changes in z-FEV1 seen in a few children were not associated with the sudden 
growth spurts that may occur at the start of puberty (Figure 3). Similar results were found 
across all ethnic groups and for FVC and FEV1/FVC (Data not shown).  
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Table 2: Distribution of children according to the magnitude of between-test variability in lung 
function, for each population. 
 
  Healthy Preterm/ LBW Prior Asthma Symptomatic ‘All Subjects’1 
 n=593 n = 63 n=37 n=65 n=758 
FEV1          
Low Variability
2
 377 (63.6%) 42 (66.7%) 27 (73.0%) 35 (53.8%) 481 (63.5%) 
Medium Variability
 
164 (27.7%) 18 (28.6%) 7 (18.9%) 22 (33.8%) 211 (27.8%) 
High Variability
  
51 (8.6%) 3 (4.8%) 2 (5.4%) 6 (9.2%) 62 (8.2%) 
Extreme Variability
  
1 (0.2%) 0 1 (2.7%) 2 (3.1%) 4 (0.5%) 
FVC 
 
   
 
 Low Variability
2 
389 (65.6%) 45 (71.4%) 27 (73.0%) 39 (60.0%) 500 (66%) 
Medium Variability
 
  150 (25.3%) 17 (27.0%) 8 (21.6%) 20 (30.8%) 195 (25.7%) 
High Variability
 
 52 (8.8%) 1 (1.6%) 1 (2.7%) 6 (9.2%) 60 (7.9%) 
Extreme Variability
 
  2 (0.3%) 0 1 (2.7%) 0 3 (0.4%) 
FEV1/FVC 
 
   
 
Low Variability
2 
370 (62.4%) 46 (73.0%) 25 (67.7%) 37 (56.9%) 478 (63.1%) 
Medium Variability
  
157 (26.5%) 11 (17.5%) 10 (27.0%) 18 (27.7%) 196 (25.9%) 
High Variability
  
62 (10.5%) 6 (9.5%) 2 (5.4%) 9 (13.8%) 79 (10.4%) 
Extreme Variability
  
4 (0.7%) 0 0 1 (1.5%) 5 (0.7%) 
 
Abbreviations: LBW: low birth weight.  
Footnote: 
1
The ‘All Subjects’ population includes all children (i.e. healthy + preterm/LBW + prior asthma + 
symptomatic at test. 
2
Classification of between-test variability: Low = change in spirometric z-score (Δ z-score) ≤ 0.5; Medium = Δ 
z-score between 0.5 and ≤ 1.0; High =  Δ z-score between 1.0 to ≤ 2.0; Extreme =  Δ z-score >2.0 
 
Inclusion of children born preterm/LBW, previously diagnosed with asthma or symptomatic 
at test occasion within the ‘All Subjects’ population had minimal effect on the distribution of 
z-score variability over time; mean (SD) difference in FEV1 z-scores being 0.07(0.59) in the 
healthy population and 0.05 (0.60) for ‘All Subjects’, with similar values for FVC and 
FEV1/FVC (Table 3).  
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Table 3: Mean differences (SD) between the two test occasions (T1-T2) in lung function z-scores for 
all populations tested. 
  n z-FEV1 z-FVC z-FEV1/FVC 
Healthy 593 0.07 (0.59) 0.04 (0.58) 0.07 (0.66) 
Preterm/LBW 63 0.01 (0.53) 0.05 (0.48) -0.08 (0.60) 
Previous asthma 37 0.05 (0.62) 0.00 (0.57) 0.08 (0.49) 
Symptomatic 65 -0.04 (0.74) -0.08 (0.63) 0.07 (0.75) 
‘All Subjects’1 758 0.05 (0.60) 0.03 (0.58) 0.06 (0.66) 
 
Abbreviations: LBW: low birth weight. 
1
 ‘All Subjects’ includes all children (i.e. healthy + preterm/LBW+ prior asthma) as well as those who were 
symptomatic on either test occasion. 
 
Although children ‘approaching puberty’ had a slightly higher odds of z-FEV1 changing by 
>0.5 z-scores over the year, this was not statistically significant (Odds Ratio (OR) 1.21; 95% 
CI: 0.76; 1.93), with similar results for FVC and FEV1/FVC (Table 4). After adjustment for 
age, time interval, pubertal status, sex and ethnicity, change in height z-score was only 
associated with an increased odds of z-FVC changing by >0.5z-scores per unit change in z-
height (Table 4). Results were similar when analysed as a continuum (data not shown). The 
magnitude of variability in lung function was independent of SEC, as measured using IMD 
2010 (data not shown) after adjusting for age, sex, height and pubertal status. 
 
Table 4: Growth factors associated with the adjusted odds of having difference in lung function (T1-
T2) > 0.5 z-scores between test occasions. 
 Δz-FEV1> 0.5 Δz-FVC> 0.5 Δz-FEV1/FVC> 0.5 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Age (at T1), per year 0.98 (0.88; 1.09) 0.86 (0.77; 0.96) 0.81 (0.73; 0.91) 
Time interval between measurements, per month 1.01 (0.95; 1.09) 1.01 (0.94; 1.09) 1.08 (1.01; 1.16) 
Difference in Height z-score (T2-T1), per unit 1.03 (0.48; 2.22) 2.51 (1.14; 5.54) 0.60 (0.28; 1.31) 
Approaching puberty vs no puberty 1.21 (0.76; 1.93) 1.04 (0.64; 1.71) 1.18 (0.73; 1.92) 
Abbreviations: Δz: change in z-scores; OR: Odds ratio; CI: Confidence Interval 
Models included all variables in the table and were additionally adjusted for sex and ethnicity.  
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DISCUSSION: 
In this study we performed repeated assessments of spirometry and anthropometry after an 
interval of 9-16 months in a large, multi-ethnic population of London primary school 
children. Although the follow-up for this study was limited to ~1 year  for practical reasons, 
this represented a clinically meaningful interval since children with lung disease frequently 
undergo detailed annual assessment (the “annual review”) in addition to more regular 
assessments throughout the year.[29] Use of the GLI ethnic-specific spirometry reference 
equations[8] were appropriate for interpreting lung function in this population, with mean 
(SD) results approximating 0 (1) z-scores on both test occasions. While two thirds of the 
children demonstrated relatively low variability in spirometric z-scores (i.e. values differed 
by less than ± 0.5z-scores (~ 6% predicted) when assessed a year apart), changes of up to 1.2 
z-scores (13%) were encountered amongst 95% of the population.  Although neither unusual 
changes in height nor transition into puberty were predictive of increased variability, there 
was a very weak inverse correlation between magnitude of change over time and initial lung 
function, this relationship being influenced primarily by the few children with lung function 
below the 5
th
 centile on the first occasion. This could reflect either slight under-performance 
by a few children on the 1
st
 occasion or undetected respirator  symptoms. However, the 
inclusion of children with mild current symptoms, prior wheeze or low birthweight did not 
influence either mean spirometry results,[13] nor the magnitude of change over time. To 
avoid potential over-treatment or unnecessary additional investigations in otherwise stable 
children, the natural year-to-year variability of lung function that can occur in the absence of 
any overt lung disease needs to be considered when interpreting results from annual reviews 
in children with lung disease.  
 
Baseline and longitudinal spirometric assessments are an integral part of routine care and 
clinical decision making for many respiratory diseases.[1-4] For example, in cystic fibrosis, 
monitoring disease progression can predict mortality and indicate need for intervention.[29] 
Liou et al recently reported relatively large individual annual decreases in FEV1 %predicted, 
with over 20% of patients having decreases >5%. They highlight the importance of 
considering individual annual changes as well as aggregated population changes,[29] 
appropriate interpretation of which requires knowledge of normal year-to-year variability. 
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In this study, after an interval of approximately 1 year, between-test variability  within ± 
1.2z-scores (approximately ±13% predicted) was achieved by 95% of young children, with 
only five children (0.7%) having extreme variability between-test occasions (> ±2z-scores). 
This is in keeping with proposals by the American Thoracic Society and European 
Respiratory Society (ATS/ERS), which suggested that  when interpreting within-subject 
annual changes, those >15% were indicative of a clinically meaningful change in adults.[5]  
This study of young school-aged children demonstrates that, provided close attention is paid 
to quality control, even in large field studies which include some mildly symptomatic 
subjects, not only is between-test variability of FEV1 and FVC similar to each other, but 
over-all variation is similar to that reported in adults. It must, however, be noted that the 
degree of variability observed in this study, where all assessments were undertaken by 
specialist staff using a highly standardised protocol, is likely to be considerably less than may 
occur in primary care, where lung function may be measured under less favourable 
conditions.   Although the magnitude of change by the second test was slightly elevated in the 
few children whose initial results fell below the normal range, the majority of children in this 
study had results within the normal range, among whom there was no relationship between 
magnitude of change and baseline lung function.  
 
Expressing differences in lung function over time as z-scores as in this study, rather than 
absolute changes[20 21] ensured appropriate adjustments were made for growth.[8] Neither 
change in height z-score nor pubertal status was associated with increased between-test 
variability of lung function, suggesting that the GLI equations adequately take such factors 
into account in young children. The current findings are however limited to children <12 
years of age and since only a relatively small proportion of these children were ‘approaching 
puberty’ we were not able to explore the differential effects of puberty on pattern of lung and 
airway growth, which remains poorly understood. Although, the assumption that longitudinal 
changes in this study follow predicted changes from the cross-sectional GLI data must be 
applied cautiously, the use of the GLI reference equations appeared to have been appropriate 
in this longitudinal study, and provided a reliable index that remained constant during 
growth. The stability of group mean spirometric z-scores over the year in this study is 
consistent with previous reports,[30 31] although these studies did not report within-subject 
variability.  
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A further strength of the study was that all assessments were undertaken by the same 
specialised team of paediatric respiratory physiologists using identical equipment and 
standardised protocols, with strict quality control criteria on both test occasions. The use of 
modern equipment and strict quality control criteria will have facilitated achievement of 
maximum FVC in these young children. This may have contributed to the slightly higher 
FVC, and hence a slightly lower FEV1/FVC than predicted by the GLI equations, as well as 
the similar variability over time of FVC when compared with FEV1. While "learning effects" 
in repeated assessments cannot be excluded,[5] the fact that the mean group lung function 
remained so stable at follow-up, suggests  that appropriate training and supervision were 
provided on both test occasions.  
 
CONCLUSION: 
Knowledge of the natural between-test variability of lung function in childhood is essential 
for appropriate interpretation of longitudinal assessments in both epidemiological studies and 
when monitoring individual children with lung disease. This study demonstrates that, even 
under optimal conditions where all assessments are undertaken by highly trained paediatric 
respiratory physiologists, lung function can vary by up to 1.2z-scores over the course of one 
year in children without any overt lung disease. Such variability is likely to be even higher in 
many hospital outpatient clinics or primary care, and must be taken into account when 
interpreting results from annual reviews in those with lung disease. Appreciation of the 
normal variability that can occur in health may help reduce anxiety for the child or their 
family, who are often alarmed at even the smallest reductions in lung function during annual 
review. Furthermore, although clinical management should always be based on treating the 
patient, rather than the numerical results of any test, awareness of the intrinsic variability of 
lung function during annual reviews may help prevent unnecessary further investigations or 
changes in treatment plans for children with lung disease who are otherwise stable. 
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